Evidence map›Paper›PMID 41978609›Full record

ArticleCureus2026

Severe Hepatocellular Injury With Transaminases > 20,000 IU/L in Suspected Repeated Drug Ingestion Despite Undetectable Serum Levels.

Vismay Patel, Rubba S Khan, Ajantha Rangasamy, Rehan Shah

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vismay PatelInternal Medicine, Hudson Regional Hospital (HRH) Bayonne University Hospital, Bayonne, USA.
Rubba S KhanInternal Medicine, Hudson Regional Hospital (HRH) Bayonne University Hospital, Bayonne, USA.
Ajantha RangasamyInternal Medicine, Hudson Regional Hospital (HRH) Bayonne University Hospital, Bayonne, USA.
Rehan ShahRheumatology, Hudson Regional Hospital (HRH) Bayonne University Hospital, Bayonne, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetaminophen toxicity is a leading cause of acute liver injury and is typically evaluated using serum acetaminophen levels and the Rumack-Matthew nomogram. However, this approach does not apply to repeated supratherapeutic ingestion or delayed presentation, where levels may be low or undetectable despite severe liver injury. We report a 38-year-old woman with alcohol use disorder who presented with epigastric pain, nausea, and vomiting and was found to have acute-on-chronic pancreatitis and marked hepatocellular injury. Her liver enzymes rapidly worsened, peaking at aspartate transferase (AST) 22,966 IU/L and alanine aminotransferase (ALT) 1,498 IU/L, while the serum acetaminophen level remained <10 µg/mL. Further history revealed repeated ingestion of approximately 9 g of acetaminophen daily for four to five days prior to admission. Intravenous N-acetylcysteine was initiated despite the undetectable level. Liver enzymes subsequently improved, and the patient remained hemodynamically stable without encephalopathy. This case highlights that an undetectable acetaminophen level does not exclude severe toxicity and emphasizes the importance of early empiric treatment when clinical suspicion is high.

Indexed as

acetaminophen toxicityacute-on-chronic pancreatitisalt (alanine aminotransferase)ast (aspartate aminotransferase)repeated supratherapeutic ingestion

Identifiers

PMID41978609
PMCPMC13070509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.